Press Coverage in 2016
Honeywell-IAI Tapped for UAV Anti-Collision Project
TEL AVIV – A US-Israel technology foundation has selected a team from Honeywell and Israel Aerospace Industries (IAI) to develop an anti-collision system aimed at allowing UAVs to operate in civilian airspace.
July 11, 2016
The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.
xAblate Neuro is manufactured by InSightec in Dallas, Texas.
Funding for the study has been provided by the Focused Ultrasound Foundation, BIRD (US-Israel Binational Industry R&D) and INSIGHTEC.
Marrone Bio Innovations and Groundwork BioAg Sign Seed Treatment Development Agreement
Key Development Initiative Focused on First Broad-Spectrum Biopesticide and Biostimulant Seed Treatment for Corn, Soybean, and Other Crops
Partial Funding Committed by BIRD Foundation
June 28, 2016, Davis, CA and Moshav Mazor, Israel. Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) and Groundwork BioAg, Ltd. (GBA) announce a collaboration to create and commercialize the world’s first all-biological comprehensive seed treatment. The treatment is expected to contain a mycorrhizal biostimulant from GBA as well as a bioinsecticide, a bionematicide, and a biofungicide from MBI.June 28, 2016
Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
The collaboration, initiated in July 2014, and supported by funding from the Binational Industrial Research and Development (BIRD) Foundation, aims to bring to market new insect control solutions – seed traits and bio-insecticides – through leveraging the expertise and distinct assets and capabilities of each party.
May 16, 2016
Something New Under the Sun
Dr. Eitan Yudilevich